128 related articles for article (PubMed ID: 8153666)
1. The chemotherapy of high-grade astrocytomas.
Lesser GJ; Grossman S
Semin Oncol; 1994 Apr; 21(2):220-35. PubMed ID: 8153666
[No Abstract] [Full Text] [Related]
2. High-dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience.
Fine HA; Antman KH
Bone Marrow Transplant; 1992 Oct; 10(4):315-21. PubMed ID: 1330152
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for high-grade gliomas.
Galanis E; Buckner J
Br J Cancer; 2000 Apr; 82(8):1371-80. PubMed ID: 10780513
[No Abstract] [Full Text] [Related]
4. [Clinical significance of mustoforan in management of malignant glioma].
Kobiakov GL
Vopr Onkol; 2007; 53(6):724-9. PubMed ID: 18416147
[No Abstract] [Full Text] [Related]
5. Regression of grade III astrocytoma during the treatment of CML with imatinib mesylate.
Jayawardena S; Sooriabalan D; Indulkar S; Kim HH; Matin A; Maini A
Am J Ther; 2006; 13(5):458-9. PubMed ID: 16988542
[TBL] [Abstract][Full Text] [Related]
6. Multi-drug versus single agent chemotherapy for high grade astrocytoma; results of a meta-analysis.
Huncharek M; Muscat J; Geschwind JF
Anticancer Res; 1998; 18(6B):4693-7. PubMed ID: 9891542
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy with cisplatin and vincristine for optic pathway/hypothalamic astrocytoma in young children.
Sawamura Y; Kamoshima Y; Kato T; Tajima T; Tsubaki J
Jpn J Clin Oncol; 2009 May; 39(5):277-83. PubMed ID: 19224939
[TBL] [Abstract][Full Text] [Related]
8. [Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma].
Linassier C; Destrieux C; Benboubker L; Alcaraz L; Bergemer-Fouquet AM; Jan M; Calais G; Colombat P
Bull Cancer; 2001 Sep; 88(9):871-6. PubMed ID: 11604360
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy in brain tumors].
van den Bent MJ; Schellens JH; Sillevis Smitt PA; Vecht CJ
Ned Tijdschr Geneeskd; 1996 Mar; 140(13):702-6. PubMed ID: 8668248
[No Abstract] [Full Text] [Related]
10. Intratumoral chemotherapy.
Walter KA; Tamargo RJ; Olivi A; Burger PC; Brem H
Neurosurgery; 1995 Dec; 37(6):1128-45. PubMed ID: 8584154
[TBL] [Abstract][Full Text] [Related]
11. NCCN: High-dose chemotherapy. Applications of high-dose chemotherapy with bone marrow/stem cell support in solid tumors.
Vaughan WP
Cancer Control; 2001; 8(6 Suppl 2):50-2. PubMed ID: 11760558
[No Abstract] [Full Text] [Related]
12. Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.
Doolittle ND; Abrey LE; Ferrari N; Hall WA; Laws ER; McLendon RE; Muldoon LL; Peereboom D; Peterson DR; Reynolds CP; Senter P; Neuwelt EA
Clin Cancer Res; 2002 Jun; 8(6):1702-9. PubMed ID: 12060607
[TBL] [Abstract][Full Text] [Related]
13. [Biological aspects of brain tumors: therapeutic implications].
Knerich R; Butti G; Robustelli della Cuna G; Gaetani P; Ubezzi G; Paoletti P
G Ital Chemioter; 1985; 32(1):77-81. PubMed ID: 3007256
[No Abstract] [Full Text] [Related]
14. [Various methodologic principles in the chemotherapy of malignant brain tumors].
Romodanov AP; Sosnov IuD
Vopr Neirokhir; 1973; 37(5):14-8. PubMed ID: 4591507
[No Abstract] [Full Text] [Related]
15. Chemotherapy for low-grade gliomas.
Mason WP
Forum (Genova); 2000; 10(2):95-104. PubMed ID: 10875972
[TBL] [Abstract][Full Text] [Related]
16. [Evolution of chemotherapy for malignant brain tumors].
Takeshima H; Kuratsu J
No Shinkei Geka; 2003 Jul; 31(7):725-34. PubMed ID: 12884787
[No Abstract] [Full Text] [Related]
17. [Resent advances in chemotherapy for malignant brain tumors].
Shibui S
Gan To Kagaku Ryoho; 2005 Apr; 32(4):442-7. PubMed ID: 15853207
[TBL] [Abstract][Full Text] [Related]
18. Advances in chemotherapy for brain tumors.
Conrad CA; Milosavljevic VP; Yung WK
Neurol Clin; 1995 Nov; 13(4):795-812. PubMed ID: 8583997
[TBL] [Abstract][Full Text] [Related]
19. Fatal course after administration of rituximab in a boy with relapsed all: a case report and review of literature.
Seifert G; Reindl T; Lobitz S; Seeger K; Henze G
Haematologica; 2006 Jun; 91(6 Suppl):ECR23. PubMed ID: 16785126
[TBL] [Abstract][Full Text] [Related]
20. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.
Fortin D; Desjardins A; Benko A; Niyonsega T; Boudrias M
Cancer; 2005 Jun; 103(12):2606-15. PubMed ID: 15880378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
